Megestrol acetate for head and neck cancer after surgery
Treatments studied
Part of Cancer, Ear, nose & throat clinical trials.
This trial tests whether a special form of megestrol acetate can help prevent cancer from coming back in people with high-risk head and neck cancer who have had surgery. It is for patients who need additional treatment with radiation or chemoradiation after their operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with squamous cell carcinoma of the head and neck (mouth, throat, voice box, or lower throat).
- You had surgery for this cancer within the last 6 weeks.
- Your doctor says you have high-risk features and need radiation with or without chemotherapy after surgery.
- You are able to eat and digest food normally (no tube feeding or IV nutrition).
- You do not have AIDS, severe nausea/vomiting, or a mental health condition causing loss of appetite.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special form of megestrol acetate (a medicine used to help with weight and appetite) can improve outcomes when given alongside standard chemotherapy and radiation for people with stage III non-small cell lung cancer. It is for patients who are not overweight and who are not already using other appetite-boosting medications.
This trial tests a medicine called megestrol acetate to see if it can prevent nausea and vomiting caused by very strong chemotherapy for lung cancer. If you are starting a strong chemo treatment, this study may help you feel better.
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
This study tests a new form of megestrol (a medicine that can boost appetite and energy) for people with advanced stomach or colorectal cancer who also have fatigue and poor appetite. It is given as a first treatment, meaning you haven't had chemotherapy yet for your advanced cancer.
This trial tests whether a medicine called megestrol acetate can help improve appetite and weight in people with advanced lung cancer who are malnourished. It's for those who haven't had chemotherapy for their advanced cancer yet.
This trial tests if taking megestrol acetate (a medicine used to stimulate appetite and help gain weight) can reduce weight loss caused by chemotherapy in people with locally advanced colorectal cancer. It may help you maintain strength and energy during treatment.
Hear when a new Head and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk Factors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.